PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance

PROCEPT BioRobotics Corp

2024-Q2 EPS reported -$1.01 revenue$97,892,000

Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).
Net loss $25.6M; Adjusted EBITDA loss $18.0M improved from $19.9M loss in prior period.
Raised FY2024 revenue guidance to ~$217M (from $213.5M); EBITDA loss guidance narrowed to $67.5M from $70M.
Gross margin reached 59% (vs 56% YoY); cash & investments $214.1M; Q2 cash usage $11.5M vs $31.6M in Q1.
Sold 47 U.S. robotic systems in Q2; U.S. install base 400; international revenue $5.7M (+79% YoY).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.